Breaking News Instant updates and real-time market news.

ZGNX

Zogenix

$52.50

-3.7 (-6.58%)

20:20
08/07/18
08/07
20:20
08/07/18
20:20

Zogenix 6M share Secondary priced at $52.00

BofA/Merrill, Leerink and Stifel acted as joint book running managers for the offering.

  • 08

    Aug

ZGNX Zogenix
$52.50

-3.7 (-6.58%)

04/20/18
MZHO
04/20/18
NO CHANGE
Target $51
MZHO
Buy
Mizuho reiterates Buy on Zogenix after GW Pharmaceuticals FDA panel
After an FDA panel unanimously voted in favor of approving GW Pharmaceuticals' (GWPH) Epidiolex, Mizuho analyst Difei Yang reiterates a Buy rating on Zogenix (ZGNX) with a $51 price target. Superior efficacy of Zogenix competitor ZX008, as demonstrated in the most recent Phase 3 results, means that FDA approval would be highly likely assuming positive data from the second Phase 3 study, expected in June, Yang tells investors in a research note. She believes readouts on the study could be an important share moving event and are "highly likely" to be positive.
07/12/18
MZHO
07/12/18
NO CHANGE
Target $69
MZHO
Buy
Zogenix price target raised to $69 from $51 at Mizuho
Mizuho analyst Difei Yang raised her view on the probability of success for ZX008 in Dravet syndrome to 100% after the company reported positive results from its second phase 3 study of the drug. Yang, who called the study "the last roadblock" prior to submitting regulatory applications in the U.S. and Europe for ZX008 in Dravet, increased her price target on Zogenix to $69 and keeps a Buy rating on the shares.
07/13/18
LEER
07/13/18
NO CHANGE
Target $92
LEER
Outperform
Zogenix price target raised to $92 from $52 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Zogenix to $92 from $52 after the company reports topline data from its second Dravet phase 3 study yesterday, stating that the data appear to represent a "best case scenario" given they approximate study one's strong efficacy and show clean cardiac safety. Porges, who thinks yesterday's 21% advance in the shares was a "reasonable reflection of the confirmation of the drug's profile," maintains an Outperform rating on Zogenix shares.
07/30/18
EAMC
07/30/18
NO CHANGE
Target $66
EAMC
Buy
Zogenix price target raised to $66 from $56 at Empire
Empire analyst Dr. Cathy Reese raised Buy rated Zogenix's price target to $66 from $56 citing a reduction in clinical development risk following Fintepla's second confirmatory Phase III study. Reese said this was the final large Fintepla clinical hurdle that needed to be cleared so Zogenix could file its U.S. and E.U. submissions for this drug to be considered as a therapy for Dravet syndrome patients.

TODAY'S FREE FLY STORIES

AGCO

Agco

$74.71

-0.53 (-0.70%)

08:14
06/24/19
06/24
08:14
06/24/19
08:14
Upgrade
Agco rating change  »

Agco upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

NVEE

NV5 Global

$79.12

0.11 (0.14%)

08:14
06/24/19
06/24
08:14
06/24/19
08:14
Hot Stocks
NV5 Global awarded $3M DCBO contract to support ENERGY 2021 initiative »

NV5 Global was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$25.19

0.83 (3.41%)

08:13
06/24/19
06/24
08:13
06/24/19
08:13
Hot Stocks
Baker Hughes, C3.ai announce joint venture agreement »

Baker Hughes, or BHGE,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

CLDX

Celldex

$2.53

-0.05 (-1.94%)

, GTXI

GTx

$0.00

(0.00%)

08:12
06/24/19
06/24
08:12
06/24/19
08:12
Hot Stocks
Celldex appoints Diane Young as SVP, CMO »

Celldex Therapeutics…

CLDX

Celldex

$2.53

-0.05 (-1.94%)

GTXI

GTx

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFRG

Del Frisco's

$6.73

-0.18 (-2.60%)

08:11
06/24/19
06/24
08:11
06/24/19
08:11
Hot Stocks
Breaking Hot Stocks news story on Del Frisco's »

Del Frisco's up 17%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Nov

KRYS

Krystal Biotech

$29.28

0.28 (0.97%)

08:10
06/24/19
06/24
08:10
06/24/19
08:10
Hot Stocks
Krystal Biotech anticipates commencing Phase 3 KB103 trial before year-end »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$29.28

0.28 (0.97%)

08:09
06/24/19
06/24
08:09
06/24/19
08:09
Hot Stocks
Krystal Biotech says safety data shows KB103 was wll-tolerated »

Krystal Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$20.68

-0.135 (-0.65%)

, CVS

CVS Health

$53.68

-0.19 (-0.35%)

08:08
06/24/19
06/24
08:08
06/24/19
08:08
Hot Stocks
Tenet, Aetna announce multi-year agreement »

Tenet (THC) and Aetna, a…

THC

Tenet

$20.68

-0.135 (-0.65%)

CVS

CVS Health

$53.68

-0.19 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RST

Rosetta Stone

$23.23

0.09 (0.39%)

08:06
06/24/19
06/24
08:06
06/24/19
08:06
Conference/Events
Rosetta Stone management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

PHR

Phreesia

$0.00

(0.00%)

08:05
06/24/19
06/24
08:05
06/24/19
08:05
Syndicate
Phreesia files registration statement for IPO »

Phreesia announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$35.22

0.2 (0.57%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Upgrade
NRG Energy rating change  »

NRG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$97.60

-0.97 (-0.98%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Conference/Events
Pinnacle West management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

BDSI

BioDelivery Sciences

$4.41

-0.05 (-1.12%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Hot Stocks
BioDelivery Sciences expands upon report from Pain Management Task Force »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAS

PhaseBio

$12.52

0.54 (4.51%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Conference/Events
PhaseBio management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

RBB

RBB Bancorp

$19.13

-0.45 (-2.30%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
RBB Bancorp announces 1M share repurchase program »

RBB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPL

Texas Pacific Land Trust

$773.00

-21 (-2.64%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
Texas Pacific Land Trust to explore conversion to C-corporation »

Texas Pacific Land Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.85

-3.94 (-3.32%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
Royal Caribbean, ITM Group partner to form new destination company »

Royal Caribbean and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTYH

GTY Technology Holdings

$7.64

-0.26 (-3.29%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
GTY Technology Holdings announces cooperative contract with Texas DIR »

GTY Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$74.34

0.94 (1.28%)

07:59
06/24/19
06/24
07:59
06/24/19
07:59
Hot Stocks
Alnylam presents new ONPATTRO results at 2019 PNS meeting »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

, UNH

UnitedHealth

$252.31

4.53 (1.83%)

07:57
06/24/19
06/24
07:57
06/24/19
07:57
Recommendations
HMS Holdings, UnitedHealth analyst commentary  »

HMS Holdings' recent…

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

UNH

UnitedHealth

$252.31

4.53 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Jul

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Caesars to adjourn Annual Meeting of shareholders »

Caesars Entertainment…

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

TTPH

Tetraphase

$0.63

-0.02 (-3.10%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Tetraphase presents new Xerava data at ASM »

Tetraphase announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

07:53
06/24/19
06/24
07:53
06/24/19
07:53
Initiation
Concert Pharmaceuticals initiated  »

SunTrust starts Concert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

WAB

Wabtec

$72.75

0.42 (0.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Downgrade
Wabtec rating change  »

Wabtec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHSP

SharpSpring

$12.84

-0.34 (-2.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Upgrade
SharpSpring rating change  »

SharpSpring upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.